← Back to Search

Behavioral Intervention

TranS-C for Mild Cognitive Impairment

N/A

Recruiting

Research Sponsored by University of California, Berkeley

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Presence of an active and progressive mental or physical illness or neurological degenerative disease

Not able and willing to participate in and/or complete the assessments and participate in the treatment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up delivered two times: at the end of the session in which non-constructive memory supports were used (baseline) and 1 week later.

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at how different types of memory support help people with mild memory loss.

Who is the study for?

This trial is for English-speaking individuals aged 60 or older who are experiencing memory loss and sleep issues. They must have mild cognitive impairment (MCI) with specific scores on the Montreal Cognitive Assessment, access to a computer and internet, and be able to attend weekly sessions. Those with progressive mental/physical illnesses or night shift work are excluded.

What is being tested?

The study tests a Transdiagnostic sleep and circadian intervention (TranS-C) aimed at improving memory in patients with mild cognitive impairment compared to those without MCI. It explores which memory support methods are most effective.

What are the potential side effects?

Since TranS-C is a non-pharmaceutical intervention focusing on behavioral strategies, significant side effects are not expected; however, participants may experience changes in their sleep patterns or stress due to new routines.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have an ongoing and worsening mental, physical, or neurological condition.

Select...

I am unable or unwilling to follow the study's procedures or treatments.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ delivered once: at the beginning of the session held 1 week after the delivery of the non-constructive memory supports

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~delivered once: at the beginning of the session held 1 week after the delivery of the non-constructive memory supports

This trial's timeline: 3 weeks for screening, Varies for treatment, and delivered once: at the beginning of the session held 1 week after the delivery of the non-constructive memory supports for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number and accuracy of applications of the material covered in the prior treatment session in which constructive memory supports were delivered

Number and accuracy of applications of the material covered in the prior treatment session in which non-constructive memory supports were delivered

Number and accuracy of thoughts about the material covered in the prior treatment session in which constructive memory supports were delivered

+3 more

Secondary study objectives

Acceptability of constructive memory support

Other study objectives

British Columbia Cognitive Complaints Inventory

Cognitive Failures Questionnaire

Learning behavior exhibited by the patient

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Constructive memory supportActive Control1 Intervention

Participants will watch videos of a sleep expert delivering treatment components from the Transdiagnostic Sleep and Circadian Intervention (TranS-C). After each video, a team member will deliver constructive memory supports.

Group II: Non-constructive memory supportActive Control1 Intervention

0 / 2Eligibility criteria met